Medtide Doubles Issued Share Capital to 141.80 Million Shares through Conversion of 68.20 Million Unlisted Shares

Bulletin Express04-08

Medtide Inc. filed its Monthly Return for Equity Issuer for March 2026, detailing a major capital restructuring that brings all outstanding shares onto The Stock Exchange of Hong Kong (HKEX).

Key developments • Share conversion: On 9 March 2026, 68.20 million previously unlisted ordinary shares were converted into the same number of H shares. • Expanded share base: Total issued share capital rose from 73.60 million to 141.80 million H shares, each with a par value of RMB 1.00. The unlisted share class was eliminated. • Authorised/issued capital: Correspondingly increased to RMB 141.80 million from RMB 73.60 million. • Public-float compliance: The company confirmed that post-conversion it satisfies the HKEX minimum public-float threshold of 25 % for the H-share class. • No other instruments: The filing shows no outstanding share options, warrants, convertible securities or treasury-share movements during the month.

Administrative details The return was submitted on 8 April 2026 by Joint Company Secretary Ng Tung Ching Raphael, affirming that all regulatory and listing-rule requirements related to the share conversion were met.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment